The DOI matches its Crossref record; 235 of the 235 references it cites were found in a registry or an index.
Extended-Spectrum β-Lactamases: a Clinical Update
Open accessAbstract
SUMMARY: Extended-spectrum β-lactamases (ESBLs) are a rapidly evolving group of β-lactamases which share the ability to hydrolyze third-generation cephalosporins and aztreonam yet are inhibited by clavulanic acid. Typically, they derive from genes for TEM-1, TEM-2, or SHV-1 by mutations that alter the amino acid configuration around the active site of these β-lactamases. This extends the spectrum of β-lactam antibiotics susceptible to hydrolysis by these enzymes. An increasing number of ESBLs not of TEM or SHV lineage have recently been described. The presence of ESBLs carries tremendous clinical significance. The ESBLs are frequently plasmid encoded. Plasmids responsible for ESBL production frequently carry genes encoding resistance to other drug classes (for example, aminoglycosides). Therefore, antibiotic options in the treatment of ESBL-producing organisms are extremely limited. Carbapenems are the treatment of choice for serious infections due to ESBL-producing organisms, yet carbapenem-resistant isolates have recently been reported. ESBL-producing organisms may appear susceptible to some extended-spectrum cephalosporins. However, treatment with such antibiotics has been associated with high failure rates. There is substantial debate as to the optimal method to prevent this occurrence. It has been proposed that cephalosporin breakpoints for the Enterobacteriaceae should be altered so that the need for ESBL detection would be obviated. At present, however, organizations such as the Clinical and Laboratory Standards Institute (formerly the National Committee for Clinical Laboratory Standards) provide guidelines for the detection of ESBLs in klebsiellae and Escherichia coli. In common to all ESBL detection methods is the general principle that the activity of extended-spectrum cephalosporins against ESBL-producing organisms will be enhanced by the presence of clavulanic acid. ESBLs represent an impressive example of the ability of gram-negative bacteria to develop new antibiotic resistance mechanisms in the face of the introduction of new antimicrobial agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“P. aeruginosa is highly resistant to various antibiotics including penicillin, cephalosporin, and aztreonam by producing extended-spectrum β-lactamases (ESBLs).246,247”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [246]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
National Committee for Clinical Laboratory Standards
Bruck, E. (1980) · Pediatrics · doi:10.1542/peds.65.1.187 · Cited by 14,751
Manual of Clinical Microbiology.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-6-939_2 · Cited by 14,411
System, A. R. F. T. N. (2003) · American Journal of Infection Control · doi:10.1016/j.ajic.2003.09.002 · Cited by 2,915
Podschun, R., & Ullmann, U. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.4.589 · Cited by 2,688
Bradford, P. A. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.933-951.2001 · Cited by 2,618
A functional classification scheme for beta-lactamases and its correlation with molecular structure
Bush, K., Jacoby, G. A., & Medeiros, A. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.6.1211 · Cited by 2,475
beta-Lactamases in laboratory and clinical resistance
Livermore, D. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.557 · Cited by 1,779
Yigit, H., Queenan, A. M., Anderson, G. J., Domenech-Sanchez, A., Biddle, J. W., Steward, C. D., Alberti, S., Bush, K., & Tenover, F. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1151-1161.2001 · Cited by 1,639
Manual of Clinical Microbiology, 7th ed.
Balows, A. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(99)00102-9 · Cited by 1,613
Jarlier, V., Nicolas, M.-H., Fournier, G., & Philippon, A. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.4.867 · Cited by 1,559
Growing Group of Extended-Spectrum β-Lactamases: the CTX-M Enzymes
Bonnet, R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.1.1-14.2004 · Cited by 1,494
Metallo-β-Lactamases: the Quiet before the Storm?
Walsh, T. R., Toleman, M. A., Poirel, L., & Nordmann, P. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.2.306-325.2005 · Cited by 1,431
Quinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,100
A standard numbering scheme for the class A β-lactamases
Ambler, R. P., Coulson, A. F. W., Frère, J. M., Ghuysen, J. M., Joris, B., Forsman, M., Levesque, R. C., Tiraby, G., & Waley, S. G. (1991) · Biochemical Journal · doi:10.1042/bj2760269 · Cited by 1,073
Serology, chemistry, and genetics of O and K antigens of Escherichia coli
Orskov, I., Orskov, F., Jann, B., & Jann, K. (1977) · Bacteriological Reviews · doi:10.1128/br.41.3.667-710.1977 · Cited by 933
Knothe, H., Shah, P., Krcmery, V., Antal, M., & Mitsuhashi, S. (1983) · Infection · doi:10.1007/bf01641355 · Cited by 912
Health Care Costs and Mortality Associated with Nosocomial Diarrhea Due to Clostridium difficile
Kyne, L., Hamel, M. B., Polavaram, R., & Kelly, C. P. (2002) · Clinical Infectious Diseases · doi:10.1086/338260 · Cited by 904
Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy
Chow, J. W., Fine, M. J., Shlaes, D. M., Quinn, J. P., Hooper, D. C., Johnson, M. P., Ramphal, R., Wagener, M. M., Miyashiro, D. K., & Yu, V. L. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-8-585 · Cited by 889
Extended-spectrum beta-lactamases
Philippon, A., Labia, R., & Jacoby, G. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1131 · Cited by 767
Lautenbach, E., Patel, J. B., Bilker, W. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/319757 · Cited by 747
More extended-spectrum beta-lactamases
Jacoby, G. A., & Medeiros, A. A. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.9.1697 · Cited by 700
Neuhauser, M. M., Weinstein, R. A., Rydman, R., Danziger, L. H., Karam, G., & Quinn, J. P. (2003) · JAMA · doi:10.1001/jama.289.7.885 · Cited by 678
Rahal, J. J. (1998) · JAMA · doi:10.1001/jama.280.14.1233 · Cited by 642
Paterson, D. L., Ko, W.-C., Gottberg, A. V., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-1-200401060-00008 · Cited by 631
Self-citationEvolution and Dissemination of β-Lactamases Accelerated by Generations of β-Lactam Antibiotics
Medeiros, A. A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s19 · Cited by 587
Nosocomial Outbreak of Klebsiella Infection Resistant to Late-Generation Cephalosporins
Meyer, K. S., Urban, C., Eagan, J. A., Berger, B. J., & Rahal, J. J. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-5-199309010-00001 · Cited by 580
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Mohapatra, S., Casellas, J. M., Goossens, H., Mulazimoglu, L., Trenholme, G., Klugman, K. P., Bonomo, R. A., et al. (2004) · Clinical Infectious Diseases · doi:10.1086/420816 · Cited by 571
Self-citationPenicillinase Synthesis Controlled By Infectious R Factors In Enterobacteriaceae
DATTA, N., & KONTOMICHALOU, P. (1965) · Nature · doi:10.1038/208239a0 · Cited by 569
(2001) · American Journal of Infection Control · doi:10.1067/mic.2001.119952 · Cited by 559
Safdar, N., & Maki, D. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-11-200206040-00013 · Cited by 556
Paterson, D. L., Ko, W.-C., Von Gottberg, A., Casellas, J. M., Mulazimoglu, L., Klugman, K. P., Bonomo, R. A., Rice, L. B., McCormack, J. G., & Yu, V. L. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.6.2206-2212.2001 · Cited by 546
Self-citationWiener, J. (1999) · JAMA · doi:10.1001/jama.281.6.517 · Cited by 485
Bradford, P. A., Bratu, S., Urban, C., Visalli, M., Mariano, N., Landman, D., Rahal, J. J., Brooks, S., Cebular, S., & Quale, J. (2004) · Clinical Infectious Diseases · doi:10.1086/421495 · Cited by 485
Woodford, N., Ward, M. E., Kaufmann, M. E., Turton, J., Fagan, E. J., James, D., Johnson, A. P., Pike, R., Warner, M., Cheasty, T., et al. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh424 · Cited by 472
Rodríguez-Baño, J., Navarro, M. D., Romero, L., Martínez-Martínez, L., Muniain, M. A., Perea, E. J., Pérez-Cano, R., & Pascual, A. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1089-1094.2004 · Cited by 456
Bradford, P. A., Urban, C., Mariano, N., Projan, S. J., Rahal, J. J., & Bush, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.3.563 · Cited by 450
Woodford, N., Tierno, P. M., Young, K., Tysall, L., Palepou, M.-F. I., Ward, E., Painter, R. E., Suber, D. F., Shungu, D., Silver, L. L., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4793-4799.2004 · Cited by 442
Poirel, L., Le Thomas, I., Naas, T., Karim, A., & Nordmann, P. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.622-632.2000 · Cited by 421
Paterson, D. L., Hujer, K. M., Hujer, A. M., Yeiser, B., Bonomo, M. D., Rice, L. B., Bonomo, R. A., & the International Klebsiella Study Group (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3554-3560.2003 · Cited by 394
Self-citationBoyd, D. A., Tyler, S., Christianson, S., McGeer, A., Muller, M. P., Willey, B. M., Bryce, E., Gardam, M., Nordmann, P., & Mulvey, M. R. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3758-3764.2004 · Cited by 389
Paterson, D. L., Mulazimoglu, L., Casellas, J. M., Ko, W.-C., Goossens, H., Von Gottberg, A., Mohapatra, S., Trenholme, G. M., Klugman, K. P., McCormack, J. G., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/313719 · Cited by 386
Self-citationRice, L. B., Willey, S. H., Papanicolaou, G. A., Medeiros, A. A., Eliopoulos, G. M., Moellering, R. C., & Jacoby, G. A. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.11.2193 · Cited by 376
Brun-Buisson, C., Legrand, P., Rauss, A., Richard, C., Montravers, F., Besbes, M., Meakins, J. L., Soussy, C. J., & Lemaire, F. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-110-11-873 · Cited by 368
Colodner, R., Rock, W., Chazan, B., Keller, N., Guy, N., Sakran, W., & Raz, R. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-003-1084-2 · Cited by 364
Carbapenem-hydrolyzing beta-lactamases
Rasmussen, B. A., & Bush, K. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.223 · Cited by 361
Karim, A., Poirel, L., Nagarajan, S., & Nordmann, P. (2001) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2001.tb10762.x · Cited by 359
Sirot, D., Sirot, J., Labia, R., Morand, A., Courvalin, P., Darfeuille-Michaud, A., Perroux, R., & Cluzel, R. (1987) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/20.3.323 · Cited by 358
Kim, Y.-K., Pai, H., Lee, H.-J., Park, S.-E., Choi, E.-H., Kim, J., Kim, J.-H., & Kim, E.-C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1481-1491.2002 · Cited by 357
Saladin, M., Cao, V. T. B., Lambert, T., Donay, J.-L., Herrmann, J.-L., Ould-Hocine, Z., Verdet, C., Delisle, F., Philippon, A., & Arlet, G. (2002) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2002.tb11126.x · Cited by 348
β-Lactamases of Kluyvera ascorbata , Probable Progenitors of Some Plasmid-Encoded CTX-M Types
Humeniuk, C., Arlet, G., Gautier, V., Grimont, P., Labia, R., & Philippon, A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.3045-3049.2002 · Cited by 338
Hanberger, H. (1999) · JAMA · doi:10.1001/jama.281.1.67 · Cited by 330
Rice, L. B., Eckstein, E. C., DeVente, J., & Shlaes, D. M. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.1.118 · Cited by 313
Fluit, A. C., Jones, M. E., Schmitz, F.-J., Acar, J., Gupta, R., Verhoef, J., & the SENTRY Participants Group (2000) · Clinical Infectious Diseases · doi:10.1086/313710 · Cited by 312
Pfaller, M. A., Jones, R. N., & Beach, M. (1999) · Clinical Infectious Diseases · doi:10.1086/598640 · Cited by 312
Peña, C., Pujol, M., Ardanuy, C., Ricart, A., Pallares, R., Liñares, J., Ariza, J., & Gudiol, F. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.53 · Cited by 311
Paterson, D. L. (2000) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2000.00107.x · Cited by 310
Self-citationCosgrove, S. E., Kaye, K. S., Eliopoulous, G. M., & Carmeli, Y. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.2.185 · Cited by 299
Pitout, J. D. D., Hossain, A., & Hanson, N. D. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.12.5715-5721.2004 · Cited by 298
Jacoby, G. A., & Han, P. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.4.908-911.1996 · Cited by 295
Poirel, L. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf240 · Cited by 284
CTX-M-type β-lactamases: an emerging group of extended-spectrum enzymes
Tzouvelekis, L. S., Tzelepi, E., Tassios, P. T., & Legakis, N. J. (2000) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(99)00165-x · Cited by 275
Kinetic interactions of tazobactam with beta-lactamases from all major structural classes
Bush, K., Macalintal, C., Rasmussen, B. A., Lee, V. J., & Yang, Y. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.851 · Cited by 274
Kang, C.-I., Kim, S.-H., Park, W. B., Lee, K.-D., Kim, H.-B., Kim, E.-C., Oh, M.-D., & Choe, K.-W. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4574-4581.2004 · Cited by 267
Poirel, L., Kämpfer, P., & Nordmann, P. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.4038-4040.2002 · Cited by 266
Emergence of Plasmid-Mediated Quinolone Resistance in Escherichia coli in Europe
Mammeri, H., Van De Loo, M., Poirel, L., Martinez-Martinez, L., & Nordmann, P. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.1.71-76.2005 · Cited by 261
Inhibitor-resistant TEM -lactamases: phenotypic, genetic and biochemical characteristics
Chaibi, E. B., Sirot, D., Paul, G., & Labia, R. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.447 · Cited by 256
(2002) · American Journal of Infection Control · doi:10.1067/mic.2002.130032 · Cited by 253
Martínez-Martínez, L., Pascual, A., Hernández-Allés, S., Alvarez-Díaz, D., Suárez, A. I., Tran, J., Benedí, V. J., & Jacoby, G. A. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1669 · Cited by 250
Schiappa, D. A., Hayden, M. K., Matushek, M. G., Hashemi, F. N., Sullivan, J., Smith, K. Y., Miyashiro, D., Quinn, J. P., Weinstein, R. A., & Trenholme, G. M. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.3.529 · Cited by 248
Thomson, K. S., & Moland, E. S. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3548-3554.2001 · Cited by 245
Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates
Smith Moland, E. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg124 · Cited by 245
Wang, M., Sahm, D. F., Jacoby, G. A., & Hooper, D. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1295-1299.2004 · Cited by 243
Vahaboglu, H., Oztürk, R., Aygün, G., Coşkunkan, F., Yaman, A., Kaygusuz, A., Leblebicioglu, H., Balik, I., Aydin, K., & Otkun, M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2265 · Cited by 236
Weldhagen, G. F., Poirel, L., & Nordmann, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2385-2392.2003 · Cited by 231
GES-2, a Class A β-Lactamase from Pseudomonas aeruginosa with Increased Hydrolysis of Imipenem
Poirel, L., Weldhagen, G. F., Naas, T., De Champs, C., Dove, M. G., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2598-2603.2001 · Cited by 228
Lautenbach, E., Strom, B. L., Bilker, W. B., Patel, J. B., Edelstein, P. H., & Fishman, N. O. (2001) · Clinical Infectious Diseases · doi:10.1086/322667 · Cited by 227
Blomberg, B., Jureen, R., Manji, K. P., Tamim, B. S., Mwakagile, D. S. M., Urassa, W. K., Fataki, M., Msangi, V., Tellevik, M. G., Maselle, S. Y., et al. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.2.745-749.2005 · Cited by 226
Poirel, L., Naas, T., Guibert, M., Chaibi, E. B., Labia, R., & Nordmann, P. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.3.573 · Cited by 224
Bauernfeind, A., Stemplinger, I., Jungwirth, R., Ernst, S., & Casellas, J. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.2.509 · Cited by 220
Laboratory procedures for the epidemiologic analysis of microorganisms
Arbeit, R. D. (1995) · Medical Entomology and Zoology · Cited by 218
Philippon, L. N., Naas, T., Bouthors, A. T., Barakett, V, & Nordmann, P. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2188 · Cited by 215
Chanawong, A., M'Zali, F. H., Heritage, J., Xiong, J.-H., & Hawkey, P. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.630-637.2002 · Cited by 211
Prevalence of Plasmid-Mediated Quinolone Resistance
Jacoby, G. A., Chow, N., & Waites, K. B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.559-562.2003 · Cited by 209
Du, B., Long, Y., Liu, H., Chen, D., Liu, D., Xu, Y., & Xie, X. (2002) · Intensive Care Medicine · doi:10.1007/s00134-002-1521-1 · Cited by 207
A Novel CTX-M β-Lactamase (CTX-M-8) in Cefotaxime-Resistant Enterobacteriaceae Isolated in Brazil
Bonnet, R., Sampaio, J. L. M., Labia, R., De Champs, C., Sirot, D., Chanal, C., & Sirot, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.7.1936-1942.2000 · Cited by 205
Ishii, Y., Ohno, A., Taguchi, H., Imajo, S., Ishiguro, M., & Matsuzawa, H. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.10.2269 · Cited by 205
Lucet, J. C., Chevret, S., Decré, D., Vanjak, D., Macrez, A., Bedos, J. P., Wolff, M., & Regnier, B. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.3.430 · Cited by 202
Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa
Nordmann, P., Ronco, E., Naas, T., Duport, C., Michel-Briand, Y., & Labia, R. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.5.962 · Cited by 201
Gniadkowski, M., Schneider, I., Pałucha, A., Jungwirth, R., Mikiewicz, B., & Bauernfeind, A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.4.827 · Cited by 198
Coque, T. M., Oliver, A., Pérez-Díaz, J. C., Baquero, F., & Cantón, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.500-510.2002 · Cited by 197
Steward, C. D., Rasheed, J. K., Hubert, S. K., Biddle, J. W., Raney, P. M., Anderson, G. J., Williams, P. P., Brittain, K. L., Oliver, A., McGowan, J. E., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.8.2864-2872.2001 · Cited by 196
Pitout, J. D. D., Hanson, N. D., Church, D. L., & Laupland, K. B. (2004) · Clinical Infectious Diseases · doi:10.1086/421094 · Cited by 192
A new plasmidic cefotaximase from patients infected withSalmonella typhimurium
Bauernfeind, A., Holley, M., Jungwirth, R., Mangold, P., Röhnisch, T., Schweighart, S., Wilhelm, R., Casellas, J. M., & Goldberg, M. (1992) · Infection · doi:10.1007/bf01704610 · Cited by 191
Zanetti, G., Bally, F., Greub, G., Garbino, J., Kinge, T., Lew, D., Romand, J.-A., Bille, J., Aymon, D., Stratchounski, L., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.11.3442-3447.2003 · Cited by 190
Gupta, A., Della-Latta, P., Todd, B., San Gabriel, P., Haas, J., Wu, F., Rubenstein, D., & Saiman, L. (2004) · Infection Control & Hospital Epidemiology · doi:10.1086/502380 · Cited by 190
Tzelepi, E., Giakkoupi, P., Sofianou, D., Loukova, V., Kemeroglou, A., & Tsakris, A. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.2.542-546.2000 · Cited by 189
Naumovski, L., Quinn, J. P., Miyashiro, D., Patel, M., Bush, K., Singer, S. B., Graves, D., Palzkill, T., & Arvin, A. M. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.9.1991 · Cited by 189
Miriagou, V., Tzouvelekis, L. S., Rossiter, S., Tzelepi, E., Angulo, F. J., & Whichard, J. M. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.4.1297-1300.2003 · Cited by 188
Novel Cefotaximase (CTX-M-16) with Increased Catalytic Efficiency Due to Substitution Asp-240→Gly
Bonnet, R., Dutour, C., Sampaio, J. L. M., Chanal, C., Sirot, D., Labia, R., De Champs, C., & Sirot, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.8.2269-2275.2001 · Cited by 188
Quinn, J. P., Miyashiro, D., Sahm, D., Flamm, R., & Bush, K. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.9.1451 · Cited by 187
Asensio, A., Oliver, A., González-Diego, P., Baquero, F., Pérez-Díaz, J. C., Ros, P., Cobo, J., Palacios, M., Lasheras, D., & Cantón, R. (2000) · Clinical Infectious Diseases · doi:10.1086/313590 · Cited by 187
Carbapenem-Resistant Strain of Klebsiellaoxytoca Harboring Carbapenem-Hydrolyzingβ-LactamaseKPC-2
Yigit, H., Queenan, A. M., Rasheed, J. K., Biddle, J. W., Domenech-Sanchez, A., Alberti, S., Bush, K., & Tenover, F. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3881-3889.2003 · Cited by 187
EXTENDED-SPECTRUM β-LACTAMASES AND OTHER ENZYMES PROVIDING RESISTANCE TO OXYIMINO-β-LACTAMS
Jacoby, G. A. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70395-0 · Cited by 184
Risk Factors for Emergence of Resistance to Broad-Spectrum Cephalosporins among Enterobacter spp
Kaye, K. S., Cosgrove, S., Harris, A., Eliopoulos, G. M., & Carmeli, Y. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2628-2630.2001 · Cited by 181
Bois, S. K. D., Marriott, M. S., & Amyes, S. G. B. (1995) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/35.1.7 · Cited by 177
Cantón, R., Oliver, A., Coque, T. M., Varela, M. D. C., Pérez-Díaz, J. C., & Baquero, F. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1237-1243.2002 · Cited by 174
Bradford, P. A., Yang, Y., Sahm, D. F., Grope, I., Gardovska, D., & Storch, G. A. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.1980 · Cited by 165
Mayer, L. W. (1988) · Clinical Microbiology Reviews · doi:10.1128/cmr.1.2.228 · Cited by 164
Poirel, L., Naas, T., Le Thomas, I., Karim, A., Bingen, E., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3355-3361.2001 · Cited by 158
Distribution of Extended-Spectrum β-Lactamases in Clinical Isolates of Enterobacteriaceae in Vietnam
Cao, V., Lambert, T., Nhu, D. Q., Loan, H. K., Hoang, N. K., Arlet, G., & Courvalin, P. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3739-3743.2002 · Cited by 156
Bauernfeind, A., Stemplinger, I., Jungwirth, R., Mangold, P., Amann, S., Akalın, E., Anğ, Ö., Bal, Ç., & Casellas, J. M. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.616 · Cited by 153
PATTERSON, J. E., Hardin, T. C., Kelly, C. C., Carvajal-García, R., & Jorgensen, J. H. (2000) · Infection Control and Hospital Epidemiology · doi:10.1086/501787 · Cited by 152
Pessoa-Silva, C. L., Moreira, B. M., Almeida, V. C., Flannery, B. L., Lins, M. C. A., Sampaio, J. L. M., Teixeira, L. M., Miranda, L. E. V., Riley, L. W., & Gerberding, J. L. (2003) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1373 · Cited by 149
Rasheed, J. K., Anderson, G. J., Yigit, H., Queenan, A. M., Doménech‐Sánchez, A., Swenson, J. M., Biddle, J. W., Ferraro, M. J., Jacoby, G. A., & Tenover, F. C. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2382-2388.2000 · Cited by 147
Pangon, B., Bizet, C., Buré, A., Pichon, F., Philippon, A., Regnier, B., & Gutmann, L. (1989) · The Journal of Infectious Diseases · doi:10.1093/infdis/159.5.1005 · Cited by 142
Girlich, D., Poirel, L., Leelaporn, A., Karim, A., Tribuddharat, C., Fennewald, M., & Nordmann, P. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.175-182.2001 · Cited by 141
Hansen, D. S., Mestre, F., Albertí, S., Hernández-Allés, S., Álvarez, D., Doménech‐Sánchez, A., Gil, J., Merino, S., Tomás, J. M., & Benedi, V. J. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.1.56-62.1999 · Cited by 141
Ceftazidime-hydrolysing CTX-M-15 extended-spectrum beta-lactamase (ESBL) in Poland
Baraniak, A., Fiett, J., Hryniewicz, W., Nordmann, P., & Gniadkowski, M. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkf151 · Cited by 136
Decousser, J., Poirel, L., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3595-3598.2001 · Cited by 136
Pai, H., Choi, E. H., Lee, H.-J., Hong, J. Y., & Jacoby, G. A. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.10.3747-3749.2001 · Cited by 135
Nordmann, P., & Naas, T. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.1.104 · Cited by 134
Munday, C. J., Whitehead, G. M., Todd, N. J., Campbell, M., & Hawkey, P. M. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh397 · Cited by 134
Rice, L. B., Carias, L. L., Hujer, A. M., Bonafede, M., Hutton, R. A., Hoyen, C. K., & Bonomo, R. A. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.362-367.2000 · Cited by 134
Self-citationBradford, P. A., Cherubin, C. E., Idemyor, V., Rasmussen, B. A., & Bush, K. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.4.761 · Cited by 133
Poirel, L., Girlich, D., Naas, T., & Nordmann, P. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.447-453.2001 · Cited by 129
Queenan, A. M., Foleno, B. D., Gownley, C., Wira, E., & Bush, K. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.1.269-275.2004 · Cited by 128
Wong‐Beringer, A., Hindler, J. A., Loeloff, M. J., Queenan, A. M., Lee, N., Pegues, D. A., Quinn, J. P., & Bush, K. (2002) · Clinical Infectious Diseases · doi:10.1086/324742 · Cited by 125
Evolution and spread of SHV extended-spectrum β-lactamases in Gram-negative bacteria
Heritage, J. C., M'Zali, F. H., Gascoyne‐Binzi, D., & Hawkey, P. M. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/44.3.309 · Cited by 124
Kruger, T., Szabó, D., Keddy, K. H., Deeley, K. B., Marsh, J. W., Hujer, A. M., Bonomo, R. A., & Paterson, D. L. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4263-4270.2004 · Cited by 124
Self-citationTenover, F. C., Mohammed, M. J., Gorton, T. S., & Dembek, Z. F. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.12.4065-4070.1999 · Cited by 124
Vercauteren, E., Descheemaeker, P. R. M., Ieven, M. M., Sanders, C. C., & Goossens, H. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.9.2191-2197.1997 · Cited by 123
Sader, H. S., Jones, R. N., Gales, A. C., Winokur, P. L., Kugler, K. C., Pfaller, M. A., & Doern, G. V. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(98)00124-2 · Cited by 122
Detection of Extended-Spectrum β-Lactamases in Klebsiellae with the Oxoid Combination Disk Method
Carter, M. W., Oakton, K. J., Warner, M., & Livermore, D. M. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.11.4228-4232.2000 · Cited by 122
Baraniak, A., Fiett, J., Sulikowska, A., Hryniewicz, W., & Gniadkowski, M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.1.151-159.2002 · Cited by 121
Bradford, P. A., Urban, C. M., Jaiswal, A., Mariano, N., Rasmussen, B. A., Projan, S. J., Rahal, J. J., & Bush, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.899 · Cited by 120
Oliver, A., Pérez-Díaz, J. C., Coque, T. M., Baquero, F., & Cantón, R. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.616-620.2001 · Cited by 120
M'Zali, F. H., Chanawong, A., Kerr, K. G., Birkenhead, D., & Hawkey, P. M. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/45.6.881 · Cited by 120
A 1998 Survey of Extended-Spectrum β-Lactamases in Enterobacteriaceae in France
de Champs, C., Sirot, D., Chanal, C., Bonnet, R., Sirot, J., & the French Study Group (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3177-3179.2000 · Cited by 118
A Novel Class A Extended-Spectrum β-Lactamase (BES-1) in Serratia marcescens Isolated in Brazil
Bonnet, R., Sampaio, J. L. M., Chanal, C., Sirot, D., de Champs, C., Viallard, J. L., Labia, R., & Sirot, J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.11.3061-3068.2000 · Cited by 118
Brigante, G., Luzzaro, F., Perilli, M., Lombardi, G., Colì, A., Rossolini, G. M., Amicosante, G., & Toniolo, A. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.09.013 · Cited by 117
ColE1-Like Plasmid pIP843 of Klebsiella pneumoniae Encoding Extended-Spectrum β-Lactamase CTX-M-17
Cao, V., Lambert, T., & Courvalin, P. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1212-1217.2002 · Cited by 117
Editorial Response: Extended-Spectrum -Lactamases: A Call for Improved Detection and Control
Paterson, D. L., & Yu, V. L. (1999) · Clinical Infectious Diseases · doi:10.1086/313559 · Cited by 113
Self-citationCotton, M. F., Wasserman, E., Pieper, C. H., Theron, D., Tubbergh, D. V., Campbell, G. D., Fang, F. C., & Barnes, J. (2000) · Journal of Hospital Infection · doi:10.1053/jhin.1999.0650 · Cited by 112
Endimiani, A., Luzzaro, F., Perilli, M., Lombardi, G., Coli, A., Tamborini, A., Amicosante, G., & Toniolo, A. (2004) · Clinical Infectious Diseases · doi:10.1086/380645 · Cited by 112
Ma, L., Ishii, Y., Ishiguro, M., Matsuzawa, H., & Yamaguchi, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1181 · Cited by 112
Sirot, D., Recule, C., Chaibi, E. B., Bret, L., Croizé, J., Chanal, C., Labia, R., & Sirot, J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.6.1322 · Cited by 110
CTX-M-1, CTX-M-3, and CTX-M-14 β-Lactamases from Enterobacteriaceae Isolated in France
Dutour, C., Bonnet, R., Marchandin, H., Boyer, M., Chanal, C., Sirot, D., & Sirot, J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.534-537.2002 · Cited by 110
Muder, R. R., Brennen, C., Drenning, S. D., Stout, J. E., & Wagener, M. M. (1997) · Infection Control and Hospital Epidemiology · doi:10.1017/s0195941700086513 · Cited by 109
Luzzaro, F., Docquier, J., Colinon, C., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.2.648-650.2004 · Cited by 109
Yan, J.-J., Ko, W., Tsai, S.-H., Wu, H., Jin, Y.-T., & Wu, J. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.12.4320-4325.2000 · Cited by 109
Plasmidic Extended-Spectrum β-Lactamases in Vibrio cholerae O1 El Tor Isolates in Argentina
Petroni, A., Corso, A. C., Melano, R. G., Cacace, M. L., Bru, A. M., Rossi, A., & Galas, M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.5.1462-1468.2002 · Cited by 109
Matsumoto, Y., & Inoue, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.307 · Cited by 108
Plasmid-Mediated Carbapenem-Hydrolyzing Enzyme KPC-2 in an Enterobacter sp
Hossain, A., Ferraro, M. J., Pino, R. M., Dew, R. B., Moland, E. S., Lockhart, T. J., Thomson, K. S., Goering, R. V., & Hanson, N. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4438-4440.2004 · Cited by 108
de Champs, C., Sirot, D., Chanal, C., Poupart, M. C., Dumas, M.-P., & Sirot, J. (1991) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/27.4.441 · Cited by 108
Hammami, A., Arlet, G., Redjeb, S. B., Grimont, F., Hassen, A. B., Rekik, A., & Philippon, A. (1991) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01975816 · Cited by 108
Early Dissemination of CTX-M-Derived Enzymes in South America
Radice, M. A., Power, P. P., Conza, J. D., & Gutkind, G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.602-604.2002 · Cited by 108
Vourli, S., Giakkoupi, P., Miriagou, V., Tzelepi, Ε., Vatopoulos, A. C., & TZOUVELEKIS, L. S. (2004) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2004.tb09535.x · Cited by 107
Kariuki, S., CORKILL, J. E., Revathi, G., Musoke, R., & Hart, C. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.7.2141-2143.2001 · Cited by 104
Bou, G., Gestal, M. C., Tomás, M., Canle, D., Molina, F., Moure, R., Bouza, J. M. E., & Guerrero, A. F. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.4030-4036.2002 · Cited by 104
Integron-Mediated Rifampin Resistance in Pseudomonas aeruginosa
Tribuddharat, C., & Fennewald, M. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.4.960 · Cited by 103
Poirel, L. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.3.561 · Cited by 102
Most Enterobacter aerogenes Strains in France Belong to a Prevalent Clone
Bosi, C., Davin‐Regli, A., Bornet, C., Malléa, M., Pagès, J., & Claude Bollet, C. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.7.2165-2169.1999 · Cited by 101
Emergence of a carbapenem-resistant Kiebsiella pneumoniae
MacKenzie, F., Forbes, K., Dorai-John, T., Amyes, S., & Gould, I. (1997) · The Lancet · doi:10.1016/s0140-6736(05)62567-6 · Cited by 101
Giakkoupi, P., TZOUVELEKIS, L. S., Tsakris, A., Loukova, V., Sofianou, D., & Tzelepi, Ε. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2247-2253.2000 · Cited by 100
Ardanuy, C., Liñares, J., Domínguez, M. Á., Hernández-Allés, S., Benedi, V. J., & Martínez-Martínez, L. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1636 · Cited by 99
Ambrose, P. G., Bhavnani, S. M., & Jones, R. N. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1643-1646.2003 · Cited by 96
Quale, J. M., Landman, D., Bradford, P. A., Visalli, M. A., Ravishankar, J., Flores, C., Mayorga, D., Vangala, K., & Adedeji, A. (2002) · Clinical Infectious Diseases · doi:10.1086/342577 · Cited by 96
TLA-1: a New Plasmid-Mediated Extended-Spectrum β-Lactamase from Escherichia coli
Silva, J., Aguilar, C., Ayala, G., Estrada, M. A., Garza–Ramos, U., Lara‐Lemus, R., & Ledezma, L. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.997-1003.2000 · Cited by 96
Macrae, M. B., Shannon, K. P., Rayner, D., Kaiser, A. M., Hoffman, P. N., & French, G. L. (2001) · Journal of Hospital Infection · doi:10.1053/jhin.2001.1066 · Cited by 95
Prodinger, W. M., Fille, M., Bauernfeind, A., et al. (1996) · Journal of Clinical Microbiology · doi:10.1128/jcm.34.3.564-568.1996 · Cited by 93
Novel Class 1 Integron (InS21) Carrying bla CTX-M-2 in Salmonella enterica Serovar Infantis
Conza, J. D., Ayala, J. A., Power, P. P., Mollerach, M. E., & Gutkind, G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2257-2261.2002 · Cited by 93
Günseren, F. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.3.373 · Cited by 93
Moland, E. S., Black, J. A., Hossain, A., Hanson, N. D., Thomson, K. S., & Pottumarthy, S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2382-2383.2003 · Cited by 91
Danel, F., Hall, L. M., Gür, D., & Livermore, D. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.785 · Cited by 90
The Brooklyn Antibiotic Resistance Task Force (2002) · Infection Control and Hospital Epidemiology · doi:10.1086/502018 · Cited by 90
Mechanisms of Decreased Susceptibility to Cefpodoxime in Escherichia coli
Oliver, A., Weigel, L. M., Rasheed, J. K., McGowan, J. E., Raney, P. M., & Tenover, F. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3829-3836.2002 · Cited by 88
Wang, H., Kelkar, S., Wu, W., Chen, M., & Quinn, J. P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.790-793.2003 · Cited by 87
Pessoa-Silva, C. L., Toscano, C. M., Moreira, B. M., Santos, A. L., Frota, A. C. C., Solari, C. A., Amorim, E. L. T., Carvalho, M. D. G. S., Teixeira, L. M., & Jarvis, W. R. (2002) · The Journal of Pediatrics · doi:10.1067/mpd.2002.127279 · Cited by 86
Rice, L. B., Yao, J. D. C., Klimm, K., Eliopoulos, G. M., & Moellering, R. C. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.6.1243 · Cited by 86
Community Transmission of Extended-Spectrum ß-Lactamase
Mirelis, B., Navarro, F., Miró, E., Mesa, R. J., Coll, P., & Prats, G. (2003) · Emerging infectious diseases · doi:10.3201/eid0908.030094 · Cited by 84
Vahaboğlu, H., Hall, L. M. C., Mülazımoğlu, L., Dodanlı, S., Yildirim, I., & Livermore, D. M. (1995) · Journal of Medical Microbiology · doi:10.1099/00222615-43-4-294 · Cited by 84
Luzzaro, F., Mantengoli, E., Perilli, M., et al. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.5.1865-1870.2001 · Cited by 84
Silva, J., Gatica-Marquina, R., Aguilar, C., Becerra, Z., Garza–Ramos, U., Velázquez, M., Miranda-Novales, M. G., Leaños-Miranda, B., Solórzano, F., & Echániz-Avilés, G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.9.3193-3196.2001 · Cited by 82
Albertini, M. T., Benoit, C., Berardi, L., Berrouane, Y., Boisivon, A., Cahen, P., Cattoen, C., Costa, Y., Darchis, P., Delière, E., et al. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1286 · Cited by 79
Monnet, D. L., Biddle, J. W., Edwards, J. R., Culver, D. H., Tolson, J. S., Martone, W. J., Tenover, F. C., Gaynes, R. P., & System, T. N. N. I. S. (1997) · Infection Control and Hospital Epidemiology · doi:10.1086/647654 · Cited by 79
Musoke, R., & Revathi, G. (2000) · Journal of Tropical Pediatrics · doi:10.1093/tropej/46.2.86 · Cited by 78
Lee, S., Lee, E. S., Park, S. Y., Kim, S.-Y., Seo, Y.-H., & Cho, Y. K. (2004) · Infection Control · doi:10.1086/502304 · Cited by 78
Castanheira, M., Mendes, R. E., Walsh, T. R., Gales, A. C., & Jones, R. N. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2344-2345.2004 · Cited by 77
Yagi, T., Kurokawa, H., Senda, K., Ichiyama, S., Ito, H., Ohsuka, S., Shibayama, K., Shimokata, K., Kato, N., Ohta, M., et al. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.12.2606 · Cited by 75
Yamasaki, K., Komatsu, M., Yamashita, T., Shimakawa, K., Ura, T., Nishio, H., Satoh, K., Washidu, R., Kinoshita, S., & Aihara, M. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg103 · Cited by 74
Chang, F., Siu, L.-K. K., Fung, C., Huang, M.-H., & Ho, M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2407-2413.2001 · Cited by 74
Thauvin-Eliopoulos, C., Tripodi, M., Moellering, R. C., & Eliopoulos, G. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1053 · Cited by 73
TZOUVELEKIS, L. S., & Bonomo, R. A. (1999) · PubMed · Cited by 73
Self-citationVahaboğlu, H., Öztürk, R., Özinel, M. A., Kocazeybek, B. S., Sahin, N., Korten, V., Tansel, Ö., Akalın, H., Tatman‐Otkun, M., Köksal, İ., et al. (2001) · Journal of Medical Microbiology · doi:10.1099/0022-1317-50-7-642 · Cited by 72
Spread ofklebsiella pneumoniae producing SHV-5 beta-lactamase among hospitalized patients
Bauernfeind, A., Eberlein, E., Holley, M., Schweighart, S., & Rosenthal, E. (1993) · Infection · doi:10.1007/bf01739303 · Cited by 70
Steward, C. D., Wallace, D., Hubert, S. K., Lawton, R. M., Fridkin, S. K., Gaynes, R. P., McGowan, J. E., & Tenover, F. C. (2000) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(00)00161-9 · Cited by 70
Kim, S., Kim, J., Kang, Y.-H., Park, Y., & Lee, B.-K. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.11.5264-5269.2004 · Cited by 68
Martı́nez-Martı́nez, L., Pascual, Á., Conejo, M. C., Garcı́a, I., Joyanes, P., Doménech‐Sánchez, A., & Benedi, V. J. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.12.3926-3932.2002 · Cited by 68
Fiett, J., Pałucha, A., ̨czyńska, B. M., Stankiewicz, M., Przondo‐Mordarska, H., Hryniewicz, W., & Gniadkowski, M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1499-1505.2000 · Cited by 67
VEB-1-like Extended-Spectrum ß-Lactamases inPseudomonas aeruginosa, Kuwait
Poirel, L., Rotimi, V. O., Mokaddas, E. M., Karim, A., & Nordmann, P. (2001) · Emerging infectious diseases · doi:10.3201/eid0703.010322 · Cited by 67
Cited by
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., Pant, S., Gandra, S., Levin, S. A., Goossens, H., & Laxminarayan, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717295115 · Cited by 3,232
Mechanisms of Antibiotic Resistance
Munita, J. M., & Arias, C. A. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.vmbf-0016-2015 · Cited by 2,782
Carbapenemases: the Versatile β-Lactamases
Queenan, A. M., & Bush, K. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00001-07 · Cited by 2,499
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies
Pang, Z., Raudonis, R., Glick, B. R., Lin, T.-J., & Cheng, Z. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.11.013 · Cited by 2,306
Metadata
- Authors
- Paterson, D. L., & Bonomo, R. A.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2005-10
- Volume
- 18
- Issue
- 4
- Pages
- 657-686
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2131946678
- Cited by
- 3,491
- References
- 235
- FWCI
- 43.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.